Making its European debut at the Rohde & Schwarz booth during the EuMW, the newly introduced FSWX signal and spectrum ...

Machine learning algorithms have been used to predict cancer progression, identify early signs of Parkinson’s disease, and ...

Besides building analytical solutions for a large-scale organization, Sree Hari Subhash, an international IT expert, has ...

Intrepid Metals Corp. (TSXV: INTR) (OTCQB: IMTCF) ("Intrepid" or the "Company") is pleased to provide assay results from a step-out diamond drill hole from the Ringo Zone, part of the ongoing 2025 ...

To this session of the Morgan Stanley Global Healthcare Conference. I'm excited to welcome the team from 4D Molecular Therapeutics. Let me just get through a quick disclosure before we get started.

Regenxbio's RGX-121 gene therapy for Hunter syndrome is the main catalyst, with FDA approval targeted for February 2026.

This study illustrates a valuable application of BID-seq to bacterial RNA, allowing transcriptome-wide mapping of pseudouridine modifications across various bacterial species. The evidence presented ...